Perindopril Arginine/Levamlodipine Besylate
精氨酸培哚普利/苯磺酸左旋氨氯地平
Report date: 2026/05/22 14:24:35
Base Information
Drug NamePerindopril Arginine/Levamlodipine Besylate
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsYes Perindopril ArginineLevamlodipine Besylate
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesNanjing Haina Pharmaceutical Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesNanjing Haina Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A